Dr. Jinming Li received his Ph.D. from Sun Yat-sen University in 2012. He worked as a postdoctoral fellow at Nanyang Technological University (Singapore), The Chinese University of Hong Kong, and University of California, Riverside. He joined Shantou University in July 2026 and is currently an Associate Professor (University-appointed) in the Department of Biomedical Engineering, College of Engineering.
Research Fields
————————————————————————————————————————————
Stem cell fate regulation based on rare-earth upconversion nanomaterials; Design of near-infrared light-controlled nanoplatforms and their applications in the diagnosis and treatment of orthopedic diseases (osteoporosis, osteoarthritis); Construction of integrated diagnosis and treatment nanocomposite hydrogels.
Education
————————————————————————————————————————————
2009.09–2012.06 Sun Yat-sen University, Chemical Biology, Ph.D.
2005.09–2008.06 Guangdong Ocean University, Aquaculture, M.S.
2001.09–2005.06 Guangdong Ocean University, Aquaculture, B.S.
Work Experience
————————————————————————————————————————————
2026.07–present Shantou University, College of Engineering, Department of Biomedical Engineering, Associate Professor (University-appointed)
2017.09–2025.12 South China Normal University, Institute of Biophotonics, Researcher, Independent PI, Master's Supervisor
2016.08–2017.08 University of California, Riverside, Postdoctoral Fellow
2014.02–2016.08 The Chinese University of Hong Kong, Postdoctoral Fellow
2012.09–2014.02 Nanyang Technological University, Postdoctoral Fellow
2008.08–2009.08 Sun Yat-sen University, School of Life Sciences, Teaching Assistant
Research Projects
————————————————————————————————————————————
National Natural Science Foundation of China (General Program), "Upconversion nanoparticle-based light-controlled induction and detection of stem cell differentiation for osteoporosis therapy" (31971267), 580,000 RMB, 2020.01–2023.12, Principal Investigator, Completed.
Publications
————————————————————————————————————————————
1. Jinming Li*, Qingxin Zhao, Jianin Sun, Hao Zeng, Anli Yang*. Near-Infrared Light-Responsive Upconversion Substrate Enables Spatiotemporal Control of Mesenchymal Stem Cells Adhesion and Multilineage Differentiation In Vivo. *Materials Today Bio*, 2025, 36, 102696. (CAS Q1, IF=10.2)
2. Zhao Luan, Xulu Ma, Qingxin Zhao, Anli Yang,*Jinming Li*. "Integrated diagnosis and treatment" of upconversion nanocomposite hydrogel for osteoarthritis treatment. *Chemical Engineering Journal*, 2024, 488, 150611. (CAS Q1, IF=13.3)
3. Xulu Ma, Zhao Luan, Qingxin Zhao, Anli Yang, *Jinming Li*. NIR-triggered release of NO by upconversion-based nanoplatforms to enhance osteogenic differentiation of mesenchymal stem cells for OP therapy. *Biomaterials Research*, 2024, 28, 0058. (CAS Q1, IF=8.1)
4. Yujiao Guo, Rui Yan, Xichao Wang, Guohai Liang, Anli Yang, *Jinming Li*. Near-infrared light-controlled activation of adhesive peptides regulates cell adhesion and multi-differentiation in mesenchymal stem cells on an up-conversion substrate. *Nano Letters*, 2022, 22, 2293–2302. (CAS Q1, IF=12.26)
5. Rui Yan, Yujiao Guo, Xichao Wang, Guohai Liang, Anli Yang, *Jinming Li*. Near-infrared light-controlled and real-time detection of osteogenic differentiation in mesenchymal stem cells by upconversion nanoparticles for osteoporosis therapy. *ACS Nano*, 2022, 16, 8399–8418. (CAS Q1, IF=18)
Patents
————————————————————————————————————————————
1. Jinming Li, Qian Wu, Kaipeng Wang, Guohai Liang. Inducer for osteogenic differentiation of mesenchymal stem cells and its preparation method. Patent No.: ZL202010140013.4, Granted.
2. Jinming Li, Kaipeng Wang, Qian Wu. Near-infrared light-controlled UCNPs carrier and its preparation method and application. Patent No.: ZL202010262128.0, Granted.
